Nirmish Singla MD MSCS
Minimally Invasive Surgery, Surgical Oncology
Urologic Oncologist/Surgeon at Johns Hopkins | Director of Translational Research in GU Oncology | Director, Kidney & Testicular Cancer Programs | Co-Director, UTUC Multidisciplinary Clinic | Vice Chair, Quality & Safety
Join to View Full Profile
10803 Falls RoadPavilion Iii Ste 3300Lutherville, MD 21093
Phone+1 410-955-6100
Fax+1 410-616-7601
Dr. Singla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2019 - 2020
University of Texas Southwestern Medical CenterFellowship, Physician Administrative Fellow, 2018 - 2019
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2018 - 2019
University of Texas Southwestern Medical CenterMSCS, Master of Science in Clinical Science, 2018 - 2019- University of Texas Southwestern Medical CenterChief Residency, Urology, 2017 - 2018
- University of Texas Southwestern Medical CenterResidency, Urology, 2014 - 2018
- University of Texas Southwestern Medical CenterInternship, Surgery, 2013 - 2014
University of Michigan Medical SchoolClass of 2013, MD- University of MichiganBSE, Biomedical Engineering, 2006 - 2009
Certifications & Licensure
MD State Medical License 2020 - 2025
NH State Medical License 2024 - 2024
TX State Medical License 2018 - 2021
NY State Medical License 2018 - 2020
American Board of Urology Urology
Publications & Presentations
PubMed
- Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance.Maximilian Pallauf, Michael Rezaee, Roy Elias, Tina Wlajnitz, Sean A Fletcher
BJU International. 2025-05-01 - Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity.Roy Elias, Thomas Nirschl, Michael Rezaee, Anirudh Yerrapragada, Shirley Wang
Cancer Research Communications. 2025-05-01 - Lack of effect of renal function on uptake of 99m Tc-sestamibi in renal masses.Alireza Amindarolzarbi, Kendall Satcowitz, Adham Khalil, Sena Osman, Salikh Murtazaliev
Nuclear Medicine Communications. 2025-05-01
Lectures
- Unraveling the molecular profile underpinning pancreatic tropisms in metastatic clear cell renal cell carcinoma.2019 ASCO Annual Meeting - 6/1/2019
- Leveraging a robust patient-derived xenograft platform to characterize predictors for engraftment and oncologic outcomes in renal cell carcinoma patients.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Prostate Cancer Consensus Conference Offers Guide to Clinical DilemmasJanuary 10th, 2023
Immunotherapy Enables Nephrectomy with Good Outcomes in Advanced RCCOctober 21st, 2019
Urology Mentors: For Many, the Quest Begins at HomeJanuary 8th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
